谷歌浏览器插件
订阅小程序
在清言上使用

Optimizing the management of HER2-negative metastatic breast cancer in the era of PARP inhibitors-proceedings from breast cancer expert group meeting

Chinese clinical oncology(2020)

引用 3|浏览5
暂无评分
关键词
Human epidermal growth factor receptor,breast cancer,BRCA mutations,poly-ADP ribose polymerase inhibitors (PARPi),immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要